The approved product labeling recommends that Ranexa be initiated at 500mg twice daily and increased to 1000mg as needed, based on clinical symptoms. Prior to the launch of the 1000mg tablet, this meant that patients taking 1000mg had to take four 500mg Ranexa tablets per day. These patients now have the option of taking two 1000mg tablets per day.
“While the 1000mg dose currently represents less than 10% of our business, CV Therapeutics is committed to providing new options that add value for doctors and patients,” said Lewis Stuart, senior vice president, commercial operations.